Stempoint Capital »

Belite Bio shares owned by Stempoint Capital

Quarter-by-quarter ownership of Belite Bio (BLTE) shares owned by Stempoint Capital from 13F filings

Historical chart of Stempoint Capital investment in Belite Bio

Tip: Access up to 7 years of quarterly data

All positions including Belite Bio held by Stempoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Belite Bio by Stempoint Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.5M 9.2k 159.96

More positions owned by Stempoint Capital

Abivax Sa Sponsored Ads (ABVX)
Scholar Rock Hldg Corp (SRRK)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Syndax Pharmaceuticals (SNDX)
Structure Therapeutics Sponsored Ads (GPCR)
Arcellx Common Stock (ACLX)
Roivant Sciences SHS (ROIV)
Terns Pharmaceuticals (TERN)
Twist Bioscience Corp (TWST)
Immunovant (IMVT)
Dyne Therapeutics (DYN)
Xenon Pharmaceuticals (XENE)
Surrozen Com New (SRZN)
Celcuity (CELC)
Mineralys Therapeutics (MLYS)

View all positions for Stempoint Capital

Top funds holding Belite Bio

Darwin Global Management
RA Capital Management
Rtw Investments
Eventide Asset Management
Point72 Asset Management
Deerfield Management Company
Marshall Wace
UBS Group
MPM Oncology Impact Management
Holocene Advisors
Western Standard
Perceptive Advisors
Goldman Sachs Group
Soleus Capital Management
ADAR1 Capital Management

View all funds holding Belite Bio